Reply

Serafin Gonzalez; Philip J. Rosenfeld; Michael W. Stewart

doi:10.1016/j.ajo.2012.05.016

Back

Journal article

Peer reviewed

Reply

Serafin Gonzalez, Philip J. Rosenfeld and Michael W. Stewart

American journal of ophthalmology, Vol.154(3), p.610

2012-09-01

DOI: https://doi.org/10.1016/j.ajo.2012.05.016

Abstract

Diabetic retinopathy

Pharmaceutical industry

Drug stores

[...]we all end up paying. Repackaged Avastin also is used for other off-label ophthalmic indications, such as diabetic macular edema, proliferative diabetic retinopathy, neovascular glaucoma, and retinopathy of prematurity.

Metrics

8 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.36 Ophthalmology; 1.36.383 Diabetic Retinopathy
Web Of Science research areas: Ophthalmology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Reply
Creators: Serafin Gonzalez
Philip J. Rosenfeld
Michael W. Stewart
Publication Details: American journal of ophthalmology, Vol.154(3), p.610
Publisher: Elsevier Limited; Chicago
Academic Unit: Miller School of Medicine; UMMG Department of Ophthalmology
Language: English
Resource Type: Journal article
Record Identifier: 991031560452902976